The Department of Experimental and Clinical Pharmacology (ECP) is at the forefront of the emerging discipline of experimental pharmacotherapeutics, providing national and international leadership in individualized medicine through prominent research and an excellent graduate program.
Faculty Spotlight
When faced with a cancer diagnosis, a patient and their care team’s primary concern is to confront and eliminate the imminent threat the cancer poses to the patient’s life and health. However, for many cancer survivors, cancer remission is not necessarily the end of health challenges related to the disease. Cancer treatment frequently causes long-term—sometimes silent—damage to critical organs and systems that can result in chronic diseases and reduce quality of life or life expectancy for cancer survivors.
Associate Professor Beshay Zordoky would like to help cancer survivors move on from illness, rather than from one illness to the next.
Read more about Dr. Zordoky's career and his work on the long-term effects of chemotherapy in the Spring 2019 issue of the ECP Gazette (PDF).
ECP Clinical and Translational Research
This cross-disciplinary paradigm translates basic scientific discoveries into safe and effective therapeutic uses by providers and patients, through laboratory experiments and clinical studies. Clinical data can also prompt new questions and investigations, leading back to the bench and beginning a new cycle of translational research.
News
On June 15th and 16th, the UMN College of Pharmacy hosted 21 pharmacists from the 2023 cohort of the Applied Pharmacogenomics for the Healthcare Workforce program for a workshop targeting pharmacists working in rural and/or underserved communities.
Program to catalyze and support adoption of pharmacogenomics on a national scale.
Ahmar U. Zaidi, MD, Medical Director, Clinical Development, Sickle Cell Disease Program at Agios Pharmaceuticals presented "The Sickle Caste: From a Single Mutation to Victimization and the Road Back".
The University of Minnesota College of Pharmacy is proud to host the nation's first Project ECHO (Extension for Community Healthcare Outcomes) program focused on pharmacogenomics-informed clinical care. Pharmacogenomics (PGx) ECHO launched in October 2021 and focuses on improving a health professional’s confidence in utilizing PGx in patient care by providing case-based education and consultation through telementoring.
The University of Minnesota College of Pharmacy has ranked third in this year’s U.S.News and World Report’s ranking of pharmacy schools.